PE 22-28 10mg is a laboratory research peptide derived from the active fragment of Spadin, a peptide linked to TREK-1 potassium channel research.
It is mainly studied in non-clinical research models involving mood-related pathways, neuroplasticity, cognitive function, memory, anxiety-response behaviour and neuroprotection.
PE 22-28 is of particular interest because researchers are exploring its potential role in rapid-acting antidepressant-like activity, brain-cell signalling, neuronal repair and emotional-response models.
This product is supplied strictly for qualified laboratory research use only and is not positioned as a medicine, supplement, antidepressant, anxiety treatment, nootropic, wellness product or performance aid.
How It Works
PE 22-28 is studied for its interaction with TREK-1 potassium channels, which are involved in neuronal activity and mood-related signalling pathways.
In research models, TREK-1 modulation is associated with changes in neuronal excitability, serotonergic signalling, BDNF expression and neuroplasticity.
BDNF, Brain-Derived Neurotrophic Factor, is commonly studied for its role in brain repair, learning, memory, synaptic plasticity and neurogenesis.
In simple terms, PE 22-28 is researched for how it may influence brain-cell communication, mood-related signalling, memory pathways and neuroprotective activity within controlled laboratory environments.
Observed Benefits
Research interest in PE 22-28 10mg includes:
- Rapid antidepressant-like effects in preclinical models.
- Mood-related pathway research.
- Cognitive-function and memory-support models.
- Neuroplasticity and BDNF signalling studies.
- Neuroprotection research.
- Anxiety-response behaviour models.
- Synaptic plasticity and brain-cell communication research.
- TREK-1 potassium channel interaction studies.
- Non-clinical neurological and emotional-response models.
These references are provided for research context only and must not be understood as human benefit claims.
Possible Side Effects
PE 22-28 10mg is supplied strictly for laboratory research purposes only and is not intended for human or animal use.
Because this product is not intended for consumption, injection, topical use or any form of in vivo use, human side-effect claims are not applicable to this product listing.
Possible research-related concerns include:
- Limited published human safety data.
- Unknown outcomes outside controlled laboratory environments.
- No approved medical-use profile.
- No approved antidepressant, anxiety, wellness or cognitive-enhancement use.
- Improper handling may create laboratory safety risks.
Bottom line: PE 22-28 remains an investigational research material and must be handled only within suitable laboratory conditions.
Reconstitution, Dosage and Cycling, Research Only
White Rabbit Labs does not provide dosing, usage, administration, application, injection, topical-use or reconstitution guidance for PE 22-28 10mg.
There are no approved human or animal dosing guidelines for this product.
This product is supplied strictly for qualified laboratory research use only. Buyers are responsible for ensuring that the material is handled in a suitable research environment and in line with applicable laws, safety standards and internal laboratory procedures.
Not for human or animal consumption. Not for injection. Not for topical use. Not for medical treatment. Not for depression treatment. Not for anxiety treatment. Not for cognitive enhancement. Not for performance enhancement. Not for any form of in vivo use.
Fun Facts
- PE 22-28 is linked to research on Spadin-derived peptide fragments.
- It is commonly discussed in relation to TREK-1 potassium channel studies.
- TREK-1 is studied in mood, neuronal excitability and neuroprotection models.
- PE 22-28 is often reviewed for its rapid antidepressant-like effects in preclinical research.
- Its main research relevance is in controlled studies involving neuroplasticity, memory, anxiety-response models and brain-cell signalling.
Citations and Sources
Most available PE 22-28 research is focused on TREK-1 channel modulation, neurological signalling, mood-related models and neuroprotection.
Key research areas include:
- TREK-1 potassium channel research.
- Spadin-derived peptide studies.
- Neuroplasticity and BDNF signalling models.
- Rapid antidepressant-like activity in preclinical research.
- Cognitive-function and memory-support models.
- Anxiety-response and emotional-regulation research.
- Neuroprotection and brain-cell repair studies.
Takeaway: PE 22-28 10mg is relevant for laboratory research involving mood-related signalling, cognitive function, neuroplasticity and neuroprotection, but it must not be interpreted as a medicine, antidepressant, anxiety treatment, nootropic, supplement or wellness product.
Our Take
PE 22-28 10mg is an interesting research peptide for laboratories studying mood-related pathways, TREK-1 potassium channels, neuroplasticity, memory and neuroprotection.
Its relevance lies in controlled neurological research environments where scientists are exploring rapid antidepressant-like activity, cognitive-response models and anxiety-related signalling.
Promising as a laboratory research material, but strictly non-clinical and not for any form of human or animal use.
Disclaimer
Important disclaimer upfront: PE 22-28 10mg is not approved by SAHPRA, the FDA, or any major regulatory authority for medical, antidepressant, anxiety, cognitive, wellness or performance use.
This product is supplied strictly for laboratory research purposes only. It is not intended for human or animal consumption, injection, topical use, medical treatment, depression treatment, anxiety treatment, cognitive enhancement, diagnosis, prevention, cure or performance enhancement.
White Rabbit Labs does not provide dosing, usage, administration, application or reconstitution guidance. Buyers are responsible for ensuring that this material is handled only within a suitable research environment and in line with applicable laws, safety standards and internal laboratory procedures.
